erythromycin has been researched along with luteolin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| He, J; Min, J; Yao, J; Yu, Z; Zhang, Q | 1 |
| Dutour, R; Poirier, D | 1 |
| Huang, H; Li, P; Liao, K; Liu, B; Liu, C; Su, W; Wang, Y; Zhou, Q | 1 |
1 review(s) available for erythromycin and luteolin
| Article | Year |
|---|---|
Inhibitors of cytochrome P450 (CYP) 1B1.
Topics: Cytochrome P-450 CYP1B1; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Humans; Molecular Structure; Structure-Activity Relationship | 2017 |
2 other study(ies) available for erythromycin and luteolin
| Article | Year |
|---|---|
Novel enoyl-ACP reductase (FabI) potential inhibitors of Escherichia coli from Chinese medicine monomers.
Topics: Anti-Bacterial Agents; Binding Sites; Computer Simulation; Curcumin; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Escherichia coli; Escherichia coli Proteins; Fatty Acid Synthase, Type II; Luteolin; Medicine, Chinese Traditional | 2010 |
Pithecellobium clypearia extract enriched in gallic acid and luteolin has antibacterial activity against MRSA and reduces resistance to erythromycin, ceftriaxone sodium and levofloxacin.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Fabaceae; Gallic Acid; Levofloxacin; Luteolin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Plant Extracts; Staphylococcal Infections; Tandem Mass Spectrometry | 2020 |